We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Technopath Clinical Diagnostics - An LGC Company

Download Mobile App


ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.

Global Coagulation Analyzers Market Driven by Growing Awareness About Timely Diagnosis of Blood Clots

By LabMedica International staff writers
Posted on 18 Jan 2022
Print article

The global coagulation analyzers market is expected to reach USD 11.7 billion by 2028, driven by the increasing understanding of blood clots and the fact that they can be avoided with early detection.

These are the latest findings of Reports and Data (New York City, NY, USA), a market research and consulting company.

Genetic disorders, as well as vitamin K deficiency and heart disease, can contribute to blood clotting. Without warning, people with pulmonary embolism sometimes die. Hence, an increase in incidences of blood clotting and the need for early detection to save lives are driving the growth of the global market for coagulation analyzers.

However, limited knowledge of timely blood clot detection and lack of qualified coagulation analyzers will hamper market growth. A substantial portion of the population in the developed countries is also unaware of the need for routine check-ups. People do not have access to proper healthcare in several under-privileged nations. These factors can pose significant challenges to the growth of the global coagulation analyzers market.

Based on product, the analyzers segment held the highest share in terms of sales of the coagulation analyzers market in 2020 and is projected to record a significant growth over the coming years. On the basis of technology, the optical technology segment is expected to hold the highest market share in the coagulation analyzers market due to the combination of immunological, chromogenic and photo-optical techniques that have resulted in the development of high-performance, multipurpose optical haemostasis analyzers.

Based on test type, the D-dimer segment is projected to account for the largest share of the coagulation analyzers market. On the basis of end-use, the clinical laboratory segment held the largest share of the coagulation analyzers market in 2020. For routine hematological examination of patients, clinical laboratory analyzers are generally used in hospitals. Based on commodity, the consumables segment holds the largest share of the coagulation analyzers market. All tests require reagents and hence, large inventories or repeat orders of these materials are maintained by hospitals, resulting in greater demand. Sales of consumables are also expected to increase along with the increase in research and development of new assays.

Geographically, the Asia Pacific coagulation analyzers market is expected to experience a lucrative growth due to sufficient hospitals, health centers and clinics in the region. With economic growth and improved access to healthcare in countries with a large population such as India and China, people are paying more attention to their health, thus generating growth opportunities for the coagulation analyzers market in the Asia Pacific region.

Related Links:
Reports and Data 

Gold Supplier
Gold Supplier
Chemistry Analyzer
Silver Supplier
Anti-Müllerian Hormone (AMH) ELISA Test
Molecular Diagnostic System
FlashDetect Flash48

Print article


Clinical Chem.

view channel
Image: The analysis pipeline used to investigate associations between blood metabolites, later life brain imaging measures, and genetic risk for Alzheimer’s disease (Photo courtesy of University College London)

Lipid Measurements Show Potential as Alzheimer’s Disease Biomarkers

Brain changes accompanying ageing are varied and can include pathologies that lead to cognitive impairment, the commonest of which is Alzheimer’s disease (AD). Identifying blood-based signatures of brain... Read more

Molecular Diagnostics

view channel
Image: Guidance UTI provides personalized results in less than one day from receipt at lab (Photo courtesy of Pathnostics)

Rapid Result Test for Complicated Urinary Tract Infections Proves Superior to Standard Urine Culture

Complicated urinary tract infections (cUTIs) are a significant burden on individual health and healthcare resources that must be diagnosed and treated early and accurately to reduce the risk of poor outcomes.... Read more


view channel
Image: The CS-2500 analyzer features pre-analytic sample checks and four detection methods simultaneously on a single platform – coagulation end-point, chromogenic kinetic analysis, turbidimetric immunoassay and automated platelet aggregation (Photo courtesy of Sysmex)

Microvascular/Endothelial Dysfunction Contributes to Post-COVID Syndrome Pathogenesis

Post-COVID syndrome (PCS) or Long-COVID is an increasingly recognized complication of acute SARS-CoV-2 infection, characterized by persistent fatigue, reduced exercise tolerance chest pain, shortness of... Read more
Copyright © 2000-2022 Globetech Media. All rights reserved.